July 21, 2021
Vaccine rollout efforts in India
Stuti Johri, 26, gets her first dose of Covishield at a private hospital in Mumbai after anxiously refreshing the CoWin app and “lucking out” in April 2021. She got her second dose seven weeks later at Kasturba Gandhi Government Hospital in Mumbai through the priority vaccination campaign for students going abroad. Johri is pursuing an MBA degree in London.
Photo by Devina Buckshee
Dispatches from India
Seema and Sanjeev Buckshee, parents of Devina Buckshee, get vaccinated with their first dose of Covishield (the name under which the Oxford-AstraZeneca vaccine was manufactured in India) at a private hospital in Mumbai in March 2021 as slots for those above age 45 opened up. At the time this photo was taken, vaccines were in stock and the entire process was smooth at this Mumbai location.
Shocking, disrespectful to the dead: Policy expert takes on govt claim of zero oxygen-related Covid deaths
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Government claim on oxygen-scarcity deaths is appalling, say experts
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Dispatches from India: Vaccine Inequity and the Pandemic Rages On
yale.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yale.edu Daily Mail and Mail on Sunday newspapers.
The emergence of the Delta and Delta Plus variants has once again put India in a state of high alert.
Two weeks after the Indian government declared the COVID-19 variant Delta Plus one of concern, health experts say the mutation, also known as AY.1 or B.1.617.2.1, has an extra mutation in the spike protein of the SARS-CoV-2 virus and poses a new challenge for the country, even with nationwide mass vaccination underway.
Initially, the Delta Plus variant was declared by India s health ministry as a variant of interest; however, later on, it was classified as a variant of concern for its characteristics of increased transmissibility, stronger binding to the receptors of lung cells and potential reduction in monoclonal antibody response.